3 Biotechs on Their Way to Monster Status Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Mark Terry, BioSpace.com Breaking News StaffWith very, very few exceptionsnamely… Source: BioSpace You Might Also Like Little reMYND Forges 350M+ Euros Tie-Up With Drug Giant Novo Nordisk December 13, 2017 Swift Biosciences Doubles Michigan HQ Space And Opens Up Shop In San Francisco October 5, 2017 IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017
IMRALDI, Biogen???s Adalimumab Biosimilar Referencing Humira, Is Approved In The European Union August 24, 2017